Literature DB >> 9217821

Depletion of stratum corneum intercellular lipid lamellae and barrier function abnormalities after long-term topical corticosteroids.

H M Sheu1, J Y Lee, C Y Chai, K W Kuo.   

Abstract

The intercellular lipid lamellae of the stratum corneum (SC) is believed to provide the permeability barrier of the epidermis. Previous functional studies have demonstrated an increase in the transepidermal water loss (TEWL) after long-term use of topical corticosteroids (TCS): however, direct morphological confirmation of this barrier abnormality is still lacking. The aim of this study was to determine whether any abnormality could be detected in the structure of the SC intercellular lipid lamellae in patients after long-term TCS. Atrophic skin and untreated normal skin of 10 patients after long-term TCS were examined by transmission electron microscopy using ruthenium tetroxide-fixed tissue for the multilamellar lipid sheets of SC, and oil red O stain for neutral lipids of the SC. Layers of the SC were evaluated by 0.1% methylene blue stain after alkaline expansion, and TEWL was measured by Evaporimeter EP1. The TCS-treated atrophic skin had fewer layers of horny cells, mean 9.4 layers, than the normal control skin, 18 layers (P < 0.001) and increased TEWL of 21.3 g/m2 compared with the control skin TEWL of 6.7 g/m2 (P < 0.01). The mean neutral lipid content of the SC was also significantly lower (P < 0.001). Moreover, ultrastructural studies revealed a marked decrease in both the numbers of intercellular lipid lamellae of SC and membrane-coating granules of stratum granulosum in the atrophic skin. These results suggest that the diminution in the SC intercellular lipid lamellae and SC cell layers play an important part in the pathogenesis of barrier dysfunction after long-term use of TCS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217821

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  17 in total

1.  Activators of PPARs and LXR decrease the adverse effects of exogenous glucocorticoids on the epidermis.

Authors:  Marianne Demerjian; Eung-Ho Choi; Mao-Qiang Man; Sandra Chang; Peter M Elias; Kenneth R Feingold
Journal:  Exp Dermatol       Date:  2009-02-19       Impact factor: 3.960

2.  Impaired nuclear translocation of glucocorticoid receptors: novel findings from psoriatic epidermal keratinocytes.

Authors:  Xiao-Yong Man; Wei Li; Jia-Qi Chen; Jiong Zhou; Lilla Landeck; Kai-Hong Zhang; Zhen Mu; Chun-Ming Li; Sui-Qing Cai; Min Zheng
Journal:  Cell Mol Life Sci       Date:  2013-01-19       Impact factor: 9.261

Review 3.  Nuclear receptor function in skin health and disease: therapeutic opportunities in the orphan and adopted receptor classes.

Authors:  Kelvin Yin; Aaron G Smith
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

4.  Topical corticosteroid application and the structural and functional integrity of the epidermal barrier.

Authors:  James Q Del Rosso; Kimberly Cash
Journal:  J Clin Aesthet Dermatol       Date:  2013-11

Review 5.  The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy.

Authors:  Emma Harris; Ana Tiganescu; Sandy Tubeuf; Sarah Louise Mackie
Journal:  Curr Rheumatol Rep       Date:  2015-06       Impact factor: 4.592

6.  Effects of Intermittent Treatment with Topical Corticosteroids and Calcineurin Inhibitors on Epidermal and Dermal Thickness Using Optical Coherence Tomography and Ultrasound.

Authors:  Roland Aschoff; Awena Lang; Edmund Koch
Journal:  Skin Pharmacol Physiol       Date:  2021-07-08       Impact factor: 3.479

7.  Pseudoceramide-containing physiological lipid mixture reduces adverse effects of topical steroids.

Authors:  Hyun Jung Kim; Hyun Jung Park; Jae Nam Yun; Se Kyoo Jeong; Sung Ku Ahn; Seung Hun Lee
Journal:  Allergy Asthma Immunol Res       Date:  2011-02-14       Impact factor: 5.764

8.  Topical steroid therapy in atopic dermatitis in theory and practice.

Authors:  Renata Jeziorkowska; Anna Sysa-Jędrzejowska; Zbigniew Samochocki
Journal:  Postepy Dermatol Alergol       Date:  2015-06-10       Impact factor: 1.837

9.  Preventive effects of multi-lamellar emulsion on low potency topical steroid induced local adverse effect.

Authors:  Geun Dong Sul; Hyun Jung Park; Jong Hwan Bae; Keum Duck Hong; Byeong Deog Park; Jaesun Chun; Se Kyoo Jeong; Seung Hun Lee; Sung Ku Ahn; Hyun Jung Kim
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

10.  Lidocaine inhibits staphylococcal enterotoxin-stimulated activation of peripheral blood mononuclear cells from patients with atopic dermatitis.

Authors:  Qingqing Jiao; Honglin Wang; Zhenglin Hu; Yin Zhuang; Weiqin Yang; Ming Li; Xia Yu; Jianying Liang; Yifeng Guo; Hui Zhang; Xilan Chen; Ruhong Cheng; Zhirong Yao
Journal:  Arch Dermatol Res       Date:  2013-04-16       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.